News2020-04-02T07:13:06+00:00

NEWS

Dr Kristian Sandberg new board member of Lipum

March 5th, 2020|

Dr Kristian Sandberg is an associate professor in immunology and an experienced leader in the pharmaceutical industry’s research and development. Sandberg has over 20 years’ experience from AstraZeneca in various functions within R&D, primarily with [...]

Lipum will attend Bio-Europe Spring 2020

February 25th, 2020|

In March Lipum will attend Bio-Europe Spring, Europe's largest partnership conference for the biotechnology industry. Meet us there! Visit site: https://informaconnect.com/bioeurope-spring/

Lipum kallar till extra bolagsstämma

February 17th, 2020|

Aktieägarna i Lipum AB, org. nr. 556813-5999, kallas härmed till extra bolagsstämma tisdagen den 3 mars 2020, kl. 13:00 på Tvistevägen 48C i Umeå. Styrelsen föreslår att Dr Kristian Sandberg väljs som ordinarie styrelseledamot i [...]

A milestone has been reached

December 18th, 2019|

After an intensive and targeted work, the cell line development of our lead drug candidate SOL-116 has been finalized. Now the production optimization and scale up has been initiated and that will provide access of [...]

Pharma Outsourcing 2019

November 26th, 2019|

“How we selected our CMO partner for cell line and production development of Lipum´s lead candidate drug SOL-116” […]

Lipum in preparation for Bio-Europe

November 5th, 2019|

– Our goal is to meet with investors interested in our next financing round,  says our CEO Einar Ponten in preparation for Bio-Europe in Hamburg, 11-13 November. […]

BioStock Life Science Summit

October 15th, 2019|

Life Science industry leaders, financing experts and qualified investors gather in Lund. Welcome to meet us at Biostock Life Science Summit, october 23th-24th. […]

INVESTOR RELATIONS